Search filters

List of works by Peter M Bruno

A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy

scientific article published on 12 November 2015

Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

scientific article published on 17 April 2020

Bidentate ligands on osmium(VI) nitrido complexes control intracellular targeting and cell death pathways

scientific article published on 16 September 2013

Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes

scientific article published on 25 January 2016

Defining principles of combination drug mechanisms of action

scientific article published on December 18, 2012

Mechanistic Studies of the Anticancer Activity of An Octahedral Hexanuclear Pt(II) Cage.

scientific article published on 25 March 2016

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

scientific article published on 18 December 2017

Necroptosis-inducing rhenium(V) oxo complexes.

scientific article

Predicting cancer drug mechanisms of action using molecular network signatures

scientific article published on January 4, 2013

Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer.

scientific article published on 7 February 2018

The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells

scientific article published on 5 July 2016

The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles

scientific article

Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity

scientific article published on 14 September 2016

Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation.

scientific article published on 20 June 2016